KR20140074996A - 인간 유두종 바이러스 치료에 유용한 구아니디닐-치환된 폴리아미드 - Google Patents

인간 유두종 바이러스 치료에 유용한 구아니디닐-치환된 폴리아미드 Download PDF

Info

Publication number
KR20140074996A
KR20140074996A KR1020147012415A KR20147012415A KR20140074996A KR 20140074996 A KR20140074996 A KR 20140074996A KR 1020147012415 A KR1020147012415 A KR 1020147012415A KR 20147012415 A KR20147012415 A KR 20147012415A KR 20140074996 A KR20140074996 A KR 20140074996A
Authority
KR
South Korea
Prior art keywords
tmg
pypypy
pypy
hpv
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147012415A
Other languages
English (en)
Korean (ko)
Inventor
제임스 케이. 바쉬킨
테리 쥐. 에드워즈
크리스토퍼 피셔
죠지 디 해리스 제이알.
케빈 제이. 쾰러
Original Assignee
나노비르, 엘엘씨
더 큐레이터스 오브 더 유니버시티 오브 미주리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나노비르, 엘엘씨, 더 큐레이터스 오브 더 유니버시티 오브 미주리 filed Critical 나노비르, 엘엘씨
Publication of KR20140074996A publication Critical patent/KR20140074996A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
KR1020147012415A 2011-10-10 2012-10-10 인간 유두종 바이러스 치료에 유용한 구아니디닐-치환된 폴리아미드 Ceased KR20140074996A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161545311P 2011-10-10 2011-10-10
US61/545,311 2011-10-10
PCT/US2012/059604 WO2013055825A2 (en) 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus

Publications (1)

Publication Number Publication Date
KR20140074996A true KR20140074996A (ko) 2014-06-18

Family

ID=48042465

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147012415A Ceased KR20140074996A (ko) 2011-10-10 2012-10-10 인간 유두종 바이러스 치료에 유용한 구아니디닐-치환된 폴리아미드

Country Status (12)

Country Link
US (1) US9133228B2 (enExample)
EP (1) EP2751096A4 (enExample)
JP (1) JP2015502330A (enExample)
KR (1) KR20140074996A (enExample)
CN (1) CN104024247B (enExample)
AU (1) AU2012322835A1 (enExample)
BR (1) BR112014008464A2 (enExample)
CA (1) CA2851516C (enExample)
HK (1) HK1201064A1 (enExample)
RU (1) RU2014113702A (enExample)
SG (1) SG11201401226YA (enExample)
WO (1) WO2013055825A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982020B2 (en) * 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
WO2016022664A1 (en) * 2014-08-05 2016-02-11 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded dna viruses
US20220193241A1 (en) * 2019-03-20 2022-06-23 Chiba-Prefecture Agent targeting double-membrane organelle dna

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7380294A (en) 1993-08-06 1995-02-28 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
EP0973740A1 (en) 1996-02-26 2000-01-26 California Institute Of Technology Design, synthesis and use of specific polyamide dna-binding ligands
CN1260006A (zh) 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
AU734715B2 (en) 1996-02-26 2001-06-21 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded DNA
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
JP2002515057A (ja) 1996-08-01 2002-05-21 カリフォルニア・インスティチュート・オブ・テクノロジー ポリアミドｄｎａ結合リガンドによる遺伝子発現の阻害
AU5910899A (en) 1998-09-11 2000-04-03 California Institute Of Technology Inhibition of oncogene transcription by synthetic polyamides
US6673940B1 (en) 1999-01-08 2004-01-06 California Institute Of Technology Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
JP4012145B2 (ja) 2001-06-25 2007-11-21 独立行政法人科学技術振興機構 ピロール−イミダゾールポリアミドの固相合成法
AU2002363523A1 (en) 2001-11-07 2003-05-19 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
BR0213988A (pt) 2001-11-07 2004-08-31 Pharmacia Corp Moduladores de poliamida de transcrição de cox2
ATE468147T1 (de) 2003-01-16 2010-06-15 Femmepharma Holding Co Inc Vaginaler oder rektaler applikator und verfahren
WO2004078943A2 (en) 2003-03-04 2004-09-16 California Institute Of Technology Alternative heterocycles for dna recognition
MXPA05011642A (es) 2003-04-30 2005-12-15 Pharmacia Corp Compuestos que tienen un resto biciclico condensado para unirse al surco menor del adn de doble hebra.
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
WO2005033282A2 (en) 2003-10-01 2005-04-14 Pharmacia & Upjohn Company Llc Polyamide compositions and therapeutic methods for treatment of human papilloma virus
DE10357677A1 (de) * 2003-12-10 2005-07-14 Greiner Bio-One Gmbh Primer und Sonden zum Nachweis genitaler HPV-Genotypen
WO2007045096A1 (en) * 2005-10-21 2007-04-26 University Of Saskatchewan Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands
WO2007103584A2 (en) 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
US8993609B2 (en) 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection
WO2007130616A2 (en) 2006-05-04 2007-11-15 Nanovir, Llc Polyamides for treating human papilloma virus

Also Published As

Publication number Publication date
JP2015502330A (ja) 2015-01-22
EP2751096A4 (en) 2015-04-08
WO2013055825A2 (en) 2013-04-18
US20130090362A1 (en) 2013-04-11
CN104024247A (zh) 2014-09-03
RU2014113702A (ru) 2015-11-20
AU2012322835A1 (en) 2014-04-17
CA2851516C (en) 2016-08-02
US9133228B2 (en) 2015-09-15
CA2851516A1 (en) 2013-04-18
EP2751096A2 (en) 2014-07-09
NZ623292A (en) 2016-02-26
CN104024247B (zh) 2016-05-25
HK1201064A1 (en) 2015-08-21
BR112014008464A2 (pt) 2017-04-11
WO2013055825A3 (en) 2013-06-13
SG11201401226YA (en) 2014-05-29

Similar Documents

Publication Publication Date Title
JP5796039B2 (ja) ヒトパピローマウイルスを処置するためのポリアミド類
CN111808136B (zh) 核苷酸类似物
WO2007103584A2 (en) Polyamides for treating human papilloma virus
US9290551B2 (en) Compounds for treating papilloma virus infection
CA2851516C (en) Guanidinyl-substituted polyamides useful for treating human papilloma virus
WO2005033282A2 (en) Polyamide compositions and therapeutic methods for treatment of human papilloma virus
US20060019927A1 (en) Anti-viral uses of borinic acid complexes
US9982020B2 (en) Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
NZ623292B2 (en) Guanidinyl-substituted polyamides useful for treating human papilloma virus
Bashkin et al. Polyamides containing amino butyric acid-based building blocks
Bashkin et al. Polyamides for treating human papilloma virus
US20200360471A1 (en) Methods of treating and preventing viral infections
WO2016022664A1 (en) Antiviral compounds and methods for treating infections caused by double-stranded dna viruses
Edwards i, United States Patent (10) Patent No.: US 9.333. 232 B2
Wilson Emerging therapies for human papillomavirus infection
WO2015161479A1 (zh) 一种嘧啶类化合物的抗宫颈癌用途
JP2960350B2 (ja) ヒト免疫不全ウイルスプロテアーゼ阻害剤、製造方法及び組成物
Nanovir Bashkin et al.(43) Pub. Date: Sep. 6, 2012
HK1229263A1 (en) Design of short oligonucleotides as vaccine adjuvants and therapeutic agents
HK1229263A (en) Design of short oligonucleotides as vaccine adjuvants and therapeutic agents
KR20010108274A (ko) 축합환 화합물 및 그 의약 용도

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140508

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140528

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150924

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160428

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150924

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160428

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20151123

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20140512

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160619

Patent event code: PE09021S01D

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20170315

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20160619

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160530

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160428

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20151123

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20150924

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20140512